59,038
Selling, general and administrative 1,493,824 1,373,062
Research and development 101,129 64,704
Total operating expenses 1,636,471 1,496,804
Operating income (loss) 729,645 (218,406)
Interest, net and other income (9,608) (13,553)
Foreign currency transaction gain (115,358) (18,572)
Income (loss) before income taxes 854,611 (186,281)
Income tax benefit - -
Net income (loss) 854,611 (186,281)
Preferred dividends 40,643 40,643
Net income (loss) attributable to common
stockholders $813,968 $(226,924)
Net income (loss) per basic common share
outstanding $0.03 $(0.01)
Basic weighted average common shares
outstanding 26,121,460 23,952,040
Net income (loss) per diluted common share
outstanding $0.03 $(0.01)
Diluted weighted average common shares
outstanding 28,688,345 26,444,924
'/>"/>SOURCE The Female Health Company Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related medicine news :1.
The Female Health Company Schedules First Quarter Conference Call for February 13, 20082.
The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application3.
Psychotherapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars4.
Females decide whether ambitious males float or flounder5.
Cancer-Suppressing Gene Tied to Female Fertility6.
Exercise May Help Female Astronauts Stay Strong7.
The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 20078.
The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 20079.
Some Female Athletes Risking Weaker Bones10.
Female Blood Donor Concern May Be Unfounded11.
Do Not Take the Pill! Dr. Prudence Hall Tells her Teen and Female Patients